Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Apr 2026 for IGC Pharma, Inc..
Filing timeline
BuySaleJames P. Moran
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
James P. Moran: trading record in brief
James P. Moran (board member) discloses dealings in IGC Pharma, Inc. to SEC (Form 4). In total, 12 filings cover trades dated from 18 January 2022 to 1 April 2026.
Every open-market trade on record is a purchase: 1 purchase worth €180k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants and 9 option exercises.
Most recently, on 6 April 2026, the filings show an option exercise in IGC Pharma, Inc. The most recent open-market purchase was published on 27 September 2024, 756 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to James P. Moran
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
80,000 shares0Common StockSEC:0001185185-26-001284:0
50,000 shares0Common StockSEC:0001185185-26-001284:1
588,235 shares@ US$0.34100.0% of flowCommon StockSEC:0001185185-24-000924:0
Canonical exit: 24 Dec 2024 (T+90)
50,000 shares0Common StockSEC:0001185185-24-000259:0
50,000 shares0Common StockSEC:0001185185-23-000670:0
50,000 shares0Common StockSEC:0001185185-22-000111:0
6 of 6 declarations
